Lethal opioids or dangerous prescribers?

Sykes NA. Thorns. Sedative use in the last week of life and the implications for end-of-life decision making. Arch. Int. Med. 2003; 163: 341-344.

Ahmedzai SH. Window of opportunity for pain control in the terminally ill. Lancet 2001; 357: 1304-1305.

Anonymous . The persistent problem with pain. Lancet 2001; 357: 1217-1217.

Borgbjerg, F , Nielsen K , Franks J. Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain 1996; 64: 123-128.

Corkery JM , Hamid Ghodse FS , Adenekan Oyefeso A. The effects of methadone and its role in fatalities. Hum Psychopharmacol: Clin Exp 2004; 19: 565-576.

Fohr S. The double effect of pain medication: separating myth from reality. J Palliat Med 1998; 1: 315-328.

Gilbert J , Kirkham S. Double effect, double bind or double speak?. Palliat Med 1999; 13: 365-366.

Good PR , Cavenagh J. Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Int Med J 2005; 35: 512-517.

Hill CSOsl . The barriers to adequate pain management with opioid analgesics. Sem Oncol. 20(Suppl 1): 1-5.

Levy M. Pain management in advanced cancer. Sem Oncol 1984; 12: 394-410.

McQuay H. Opioids in pain management. Lancet 1999; 353: 2229-2232.

Morita TT , Inoue J , Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Sympt Manag 2001; 21: 282-289.

Portenoy R. Appropriate use of opioids for persistent non-cancer pain. Lancet 2004; 364: 739-740.

Portenoy R , Lesage P. Management of cancer pain. The Lancet 1999; 353: 1695-1700.

Portenoy RK , Coyle N. Controversies in the long-term management of analgesic therapy in patients with advanced cancer. J Pain Sympt Manag 1990; 5: 307-319.

Regnard C , Badger C. Opioids, Sleep and the time of death. Palliat Med 1987; 1: 107-110.

Thorns A. More openness needed in palliative care. Doctrine of double effect means that death is not intended. BMJ 1998; 316: 391-391.

Thorns A , Sykes N. Opioid use in last week of life and implications for end-of-life decision-making. Lancet 2000; 356: 398-399.

Turner K , Chye R , Aggarwal G , Philip J , Skeels A , Lickiss JN. Dignity in dying: a preliminary study of patients in the last three days of life. J Palliat Care 1996; 12: 7-13.

Twycross R. Ethical and clinical aspects of pain treatment in cancer patients. Acta Anaesthesiologica Scandinavia 1982; 74(Suppl): 83-90.

Wall P. The generation of yet another myth on the use of narcotics. Pain 1997; 73: 121-122.

Walsh T. Opiates and respiratory function in advanced cancer. Recent Results Cancer Res 1984; 41: 115-117.

Hanks G , Cherny N , Fallon M. Opioid analgesic therapy. In Doyle D. et al. , eds. Oxford Textbook of Palliative Medicine. Oxford University Press, 2004: 316-341.

Portenoy R. Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symp Manag 2006; 32: 532-540.

Chan J , Treece PD , Engelberg RA , et al. Narcotic and benzodiazepine use after withdrawal of life support: association with time to death?. Chest, 2004; 126: 286-293.

Edwards M. Opioids and benzodiazepines appear paradoxically to delay inevitable death after ventilator withdrawal. J Palliat Care, 2005; 21: 299-302.

Estfan B , Mahmoud F , Shaheen P , et al. Respiratory function during parenteral opioid titration for cancer pain. Palliat Med 2007: 21: 81-86.

Hu WC , Cheng TY , Chen CY. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan? J Pain Symp Manag 2004; 28: 356-363.

Mazzocato CBT , Rapin CH. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Annals Oncol 1999; 10: 1511-1514.

Boyd K , Kelly M. Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer. Palliat Med 1997; 11: 277-281.

Bruera E , Macmillan K , Pither RT , McDonald RN. Effects of morphine on the dyspnoea of terminal cancer patients. J Pain Sympt Manag 1990; 5: 341-344.

Rurup M , Onwuteaka-Philipsen BD , van der Heide A , van der Wal G , van der Mass PJ. Trends in the agents used for euthanasia and the relationship with the number of notifications. Nederlands Tijdschrift voor Geneeskunde 2006; 150: 618-624.

Schmidt C. Carotid sinus reflexes to the respiratory centre: I. Identification. Am J Physiol 1932; 102: 94-119.

Devlin JRv . Adams (Bodkin), in Crim. Law Rev. 1957.

Dyer C. British GP cleared of murder charge. BMJ 1999; 318: 1306a-1306a.

Walton of Detchant, L. , Select Committee on Medical Ethics Report. 1994, House of Lords: The Stationary Office. p. 3 vols.

Seale C. National survery of end-of-life decisions made by UK medical practitioners. Palliat Med 2006; 20: 3-10.

Seale C. Characteristics of end-of-life decisions: survey of UK medical practitioners. Palliat Med 2006; 20: 653-659.

Kuhse H , Singer P , Braume P , Clark M , Richard M. End-of-life decisions in Australian medical practice. Med J Aust 1997; 166: 191-196.

van der Heide A , et al. End-of-life decision-making in six European countries: descriptive study. Lancet 2003; 362: 345-350.

Forbes K , Huxtable R. Clarifying the data on double effect. Palliat Med, 2006; 20: 395-395.

Ashby M. The fallacies of death causation in palliative care. Med J Aust, 1997; 166: 176-177.

Doyal L. When doctors might kill their patients: The moral character of doctors or the best interests of patients? BMJ 1999; 318: 1432-1433.